Skip to main content
Clinical Trials/DRKS00017767
DRKS00017767CompletedNot Applicable

Quality of life in patients with nonalcoholic fatty liver disease

niversitätsklinikum Leipzig, Klinik für Gastroenterologie0 sites121 target enrollmentStarted: July 30, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
121

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to 100 Years (—)
Sex
All

Inclusion Criteria

  • 1) Age >18 years
  • 2) Written informed consent
  • 3) Clinical diagnosis of nonalcoholic fatty liver disease

Exclusion Criteria

  • 1) Participation in a clinical trial for the treatment of NAFLD
  • 2) Existence of additional liver disease other than NAFLD
  • 3) Alcohol consumption >30 g / d in men or >20 g / d in women
  • 4) Language barrier with limited knowledge of German
  • 5) Presence of hepatocellular carcinoma
  • 6) Organ transplant recipient
  • 7) Pregnancy and breastfeeding
  • 8) Liver cirrhosis Child B or Child C

Investigators

Sponsor
niversitätsklinikum Leipzig, Klinik für Gastroenterologie

Similar Trials

Unknown
Not Applicable
Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)Non-Alcoholic Fatty Liver Disease
NCT03613480University Hospital of Patras100
Recruiting
Not Applicable
The effect of treatment of non-alcoholic fatty liver with zucchini in pregnant women on the gestational Diabeteson-alcoholic Fatty Liver , Gestational Diabetes Mellitus.Fatty (change of) liver, not elsewhere classifiedK76.0
IRCT20200419047137N1Arak University of Medical Sciences60
Active, not recruiting
Phase 1
Soft Tissue sarkomas (STS) are rare tumors, orginated from connectivetissue and supporting connective tissue. For patients with progressedSTS are different options for palliative treatment. In PazoQol the twooptions Chemotherapy and Pazopanib should be compared with focus onpatient reported outcomes.Soft tissue sarcoma (STS)MedDRA version: 15.1Level: HLGTClassification code 10041299Term: Soft tissue sarcomasSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: HLTClassification code 10041298Term: Soft tissue sarcomas histology unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10075333Term: Soft tissue sarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-003382-10-DEGWT-TUD GmbH150
Not yet recruiting
Phase 2
Clinical features of fatty liver in non alcoholic and its association with obesity, type 2 diabetes
CTRI/2022/07/044146DR Basavesh Gongadashetti
Not yet recruiting
Phase 2
To study the effect of Safuf-e-Zaranbad in patients with Non-Alcoholic Fatty Liver Disease
CTRI/2023/03/050355Central Council for Research in Unani Medicine New Delhi